News | May 18, 2021
Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
The company will review FDA's response and decide on appropriate next steps soon.
The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
The Union Minister reviewed DST-supported SATHI-BHU facility
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
Subscribe To Our Newsletter & Stay Updated
